Impact BioMedical, Inc. (IBO) support and resistance · rev $18.0K
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
This page maps Impact BioMedical, Inc. (IBO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
IBO currently screens at market cap $7.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IBO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IBO quote page for the session range and the stock page for the full model.
Not investment advice.